Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07355322

Comparison of a 3-step Bonding System (Transbond™ XT) and a 2-step System (GC Ortho Connect™) on Demineralization Around Maxillary Orthodontic Brackets

White spot lesions (WSLs) are one of the most common adverse effects of fixed orthodontic treatments, affecting up to 97% of patients treated with labial appliances. These early enamel demineralizations, caused by microleakage between enamel and adhesive, can appear as early as the fourth week of treatment. They not only pose aesthetic concerns but also increase the risk of bracket failure.

This randomized split-mouth clinical trial compares two bonding systems : the traditional three-step system (Transbond™ XT) and the simplified two-step system (GC Ortho Connect™) to assess their impact on enamel demineralization around orthodontic brackets. The degree of demineralization will be measured using the Enamel Decalcification Index (EDI) based on intraoral photographs and confirmed with a fluorescence camera (C50 Acteon).

The aim of the study is to determine whether the simplified bonding protocol can reduce clinical time and saliva contamination risk without increasing enamel demineralization, thus offering a potentially more efficient and conservative approach for orthodontic bonding procedures.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

10 year–16 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Introduction:

White spot lesions (WSLs) (localized, non-cavitated enamel demineralizations) represent one of the most frequent side effects of fixed orthodontic treatments. Clinically visible in up to 97% of patients undergoing labial orthodontic therapy, these lesions can emerge as early as the fourth week of treatment. They result from microleakage at the adhesive enamel interface, which facilitates bacterial colonization and acid production. Beyond their aesthetic impact, WSLs can compromise bracket adhesion and increase the risk of failure

Fixed orthodontic appliances modify the oral ecosystem, favoring plaque accumulation and hindering efficient brushing, particularly around complex elements such as ligatures, brackets, and springs. Consequently, WSLs constitute a significant clinical concern for both orthodontists and dental surgeons, as these lesions can persist five years after treatment completion.

Bonding Systems Under Investigation :

The conventional bonding protocol, Transbond™ XT, involves three steps: etching, primer application, and adhesive placement. Conversely, the GC Ortho Connect™ system integrates the primer directly into the adhesive, simplifying the bonding procedure to a single step following orthophosphoric acid etching. This reduced protocol minimizes saliva exposure time and enhances bonding strength.

Furthermore, GC Ortho Connect™ contains functional monomers such as 10-MDP (10-methacryloyloxydecyl dihydrogen phosphate), which chemically interacts with hydroxyapatite, forming a stable bond resistant to moisture. While some studies suggest this system reduces the risk of contamination and shortens chairside time, others report slightly deeper and larger lesions compared to the conventional three-step approach. Evidence remains contradictory, with several in vitro studies showing no significant difference in enamel quality between the two bonding systems.

Research Hypothesis and Objectives :

This clinical trial aims to determine whether a significant difference exists in enamel demineralization between a three-step (Transbond™ XT) and a two-step (GC Ortho Connect™) bonding system.

  • Primary Objective: Compare the degree of enamel demineralization around orthodontic brackets at debonding between the two systems using intraoral photographs (Enamel Decalcification Index, EDI) and fluorescence imaging (C50 Acteon camera).
  • Secondary Objectives:
  • Assess enamel demineralization before bonding, at 6 months, and at 12 months.
  • Compare bracket failure rates throughout treatment.
  • Evaluate plaque accumulation using the Silness and Löe plaque index.

Methodology :

A monocentric randomized split-mouth trial will be conducted at the Montpellier Dental Care Center. Each patient will serve as their own control:

One hemi-arch (control) bonded with Transbond™ XT (3-step system).

The opposite hemi-arch (experimental) bonded with GC Ortho Connect™ (2-step system).

Randomization will be stratified by gender and brushing hand dominance to reduce confounding factors. Inclusion criteria target minors aged 10-16 years requiring fixed labial metallic appliances.

The split-mouth design minimizes interindividual variability (e.g., enamel quality, saliva composition, hygiene habits) and increases statistical power. Additionally, enamel demineralization assessment will be conducted by a blinded examiner to ensure unbiased evaluation.

Conclusion :

This study proposes an innovative clinical comparison between two orthodontic bonding systems to assess their effects on enamel demineralization. If the simplified GC Ortho Connect™ system demonstrates similar or superior outcomes to the conventional Transbond™ XT, it could represent a time-saving, contamination-resistant, and more conservative alternative for orthodontic bonding procedures ultimately improving patient safety and clinical efficiency.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient aged 10 to 16 years included,
  • Patient attending their first dentofacial orthopedics consultation at the Montpellier Dental Care Center, in adolescent or young adult dentition (according to Démogé classification),
  • Patient requiring the placement of a bimaxillary multi-bracket treatment and opting for a metallic vestibular technique.

Exclusion criteria

  • Syndromic patient (all syndromes included, e.g., cleft lip) or with a severe long-term condition (ALD),
  • Patient previously treated with a multi-bracket orthodontic treatment using a mixed, lingual, or vestibular technique,
  • Any medical condition deemed incompatible with bracket placement by the investigator,
  • Patient with severe MIH (molar-incisor hypomineralization) and/or severe demineralization on one or more teeth (including severe amelogenesis imperfecta or dentinogenesis imperfecta),
  • Patient with restorations such as metal crowns, ceramic crowns, porcelain-fused-to-metal crowns, inlays, onlays, or amalgam on one or more vestibular surfaces,
  • Patient with oral hygiene incompatible with orthodontic treatment,
  • Agenesis of lateral incisors,
  • Subject already participating in another interventional clinical trial that could interfere with this study,
  • Uncontrolled psychiatric disorder,
  • Lack of written informed consent from a legal representative after a reflection period,
  • Lack of cooperation or difficulty in communication/comprehension, or refusal of participation by the minor,
  • Subject with a dependency or employment relationship with the sponsor or investigator,
  • Subject participating in another research study with an ongoing exclusion period,
  • Subject not affiliated with the French social security system or not a beneficiary of such a system,
  • Protected populations according to the French Public Health Code:

Pregnant or breastfeeding women Subjects deprived of liberty (by judicial, administrative decision, or involuntary hospitalization) Subjects under guardianship or curatorship

Treatment and study plan

Transbond™ XT bonding procedure

Device

Brackets are bonded to one hemi-arch using the 3-step protocol: 1) acid etching, 2) primer application, 3) adhesive placement and light curing.

GC Ortho Connect™ bonding procedure

Device

Brackets are bonded to the contralateral hemi-arch using the 2-step protocol: 1) acid etching, 2) adhesive with integrated primer, followed by light curing.

Primary outcomes

  1. Mean Enamel Decalcification Index (EDI) after Debonding

    Time frame: Up to 24 months

    Mean Enamel Decalcification Index (EDI) per maxillary hemi-arch after debonding of fixed orthodontic appliances. The assessment will be performed using intraoral photographs, based on the 0-3 scoring system of the Enamel Decalcification Index (EDI) by Banks & Richmond, 1994, evaluating white spot lesions (WSLs) around maxillary metallic orthodontic brackets (AO groove .022 x .028). Results will be confirmed using a fluorescence intraoral camera.

Secondary outcomes

  1. Mean EDI per Hemi-Arch

    Time frame: Preprocedural

    Mean Enamel Decalcification Index (EDI) per maxillary hemi-arch, using intraoral photographs and fluorescence intraoral camera, to the 0-3 scoring system of the Enamel Decalcification Index (EDI) by Banks & Richmond, 1994.

  2. Mean EDI per Hemi-Arch

    Time frame: 6 months

    Mean Enamel Decalcification Index (EDI) per maxillary hemi-arch, using intraoral photographs and fluorescence intraoral camera, to the 0-3 scoring system of the Enamel Decalcification Index (EDI) by Banks & Richmond, 1994.

  3. Mean EDI per Hemi-Arch

    Time frame: 12 months

    Mean Enamel Decalcification Index (EDI) per maxillary hemi-arch, using intraoral photographs and fluorescence intraoral camera, to the 0-3 scoring system of the Enamel Decalcification Index (EDI) by Banks & Richmond, 1994.

  4. EDI per Tooth

    Time frame: Preprocedural

    Enamel Decalcification Index (EDI) measured per tooth, according to the 0-3 EDI scoring system.

  5. EDI per Tooth

    Time frame: 6 months

    Enamel Decalcification Index (EDI) measured per tooth, according to the 0-3 EDI scoring system.

  6. EDI per Tooth

    Time frame: 12 months

    Enamel Decalcification Index (EDI) measured per tooth, according to the 0-3 EDI scoring system.

  7. EDI per Tooth

    Time frame: Up to 24 months

    Enamel Decalcification Index (EDI) measured per tooth, according to the 0-3 EDI scoring system.

  8. Occurrence of bracket Detachment per tooth

    Time frame: 6 months

  9. Occurrence of bracket Detachment per tooth

    Time frame: 12 months

  10. Occurrence of bracket Detachment per tooth

    Time frame: Up to 24 months

  11. Total number of detachments per tooth

    Time frame: 6 months

  12. Total number of detachments per tooth

    Time frame: 12 months

  13. Total number of detachments per tooth

    Time frame: Up to 24 months

  14. Total number of detachments per patient

    Time frame: 6 months

  15. Total number of detachments per patient

    Time frame: 12 months

  16. Total number of detachments per patient

    Time frame: Up to 24 months

  17. Plaque Index

    Time frame: Preprocedural

    Plaque Index scored 0-3 according to Silness & Loe, measured with a probe N°6

  18. Plaque Index

    Time frame: 6 months

    Plaque Index scored 0-3 according to Silness & Loe, measured with a probe N°6

  19. Plaque Index

    Time frame: 12 months

    Plaque Index scored 0-3 according to Silness & Loe, measured with a probe N°6

  20. Plaque Index

    Time frame: Up to 24 months

    Plaque Index scored 0-3 according to Silness & Loe, measured with a probe N°6

Study contacts

Contact information is provided by the study sponsor or research team.

Stéphane BARTHELEMI, PU-PH

CONTACT

[email protected]

+33 6 47 75 55 33

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Official study title

Comparison of a 3-step Bonding System (TRANSBOND™ XT) Versus a 2-step System (GC ORTHO CONNECT™) on Demineralization Around Maxillary Orthodontic Brackets: a Randomized Split-mouth Clinical Trial.

Acronym: ORTHOCOLLAGE

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Jan 21, 2026
Registry last updated
Jan 21, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.